Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
very engaged, close to the employees
What is the best part about your compensation package?
annual bonus is fairly distributed
What are some of the best things about your team?
team members are knowledgeable and we help each other
What is most positive about the culture and environment at your company?
the thinking and all the activities are for the patients
What makes you most happy at work?
I have got the opportunity to be involved in the development of the drug until market approval
Other Employee Reviews for Karyopharm Therapeutics
×